Immunometabolic pathways are activated in MDD with elevated CRP (1–3 mg/L) or low-grade inflammation (>3 mg/L) vs. controls, while cell-cycle-related pathways are inhibited in MDD with low levels of CRP ( < 1 mg/L) vs. controls. This evidence concerns the gene CRP and major depressive disorder.